Ruti Aga's Six-Year Ban: The Forged Prescription Destroyed the One Defence That Could Have Worked

That Morning in March, and the Date Missing From the File

Somewhere in March, at a half marathon in China, Ruti Aga crossed the line first. The report gives no race name, no finish time, no weather, no field quality. What it gives is a win, a subsequent in-competition sample, and methylprednisolone in that sample. On Thursday the Athletics Integrity Unit (AIU) issued a statement in which two sanctions were laid end to end: two years for presence, four years for tampering. Six years in total, running from 10 September. Age 32. Age 38 on return.

The first duty here is to record what the report does not contain. Not the year of the March race. Not the year the ban began. Not the race name. Not the mark. Not whether the March result and its prize money were annulled. These look marginal in a disciplinary story. They are exactly where I stop my pen. On the day an athlete is removed for six years, the urgent question is not what happened — it is what went unrecorded.

Under the headline there is a smaller story, and it is usually the true one. The headline is a marathon runner banned for six years over a fake prescription. The smaller story is that a 32-year-old had a legitimate defence available to her, and destroyed it with her own hands.

What the Document Says, and What It Refuses To Say

AIU's statement rests on two charges. First, presence of a prohibited substance. Second, tampering — misleading information during investigation and the production of a fabricated document. Two years on the first, four on the second. That arithmetic signals that the panel did not find intent proven on presence, but held her fully culpable on tampering.

Second point: provisional suspension ran from 10 September, and the ban was also dated from 10 September. This is routinely reported as a concession. It is accounting. Provisional suspension time counts against the ban because the athlete served that time anyway. Nothing is forgiven. The ledger shows a clean entry, not a discount.

Third — and this is where I stopped — the tampering charge came from an interview, not from a document. Language and interpretation in AIU interviews with Ethiopian athletes has been a recurring point of friction. I am not claiming translation decided this case. I am claiming that when the largest part of a sanction rests on spoken words, the record of those words matters as much as the record of the sample.

The File Was Open Before the World Had a Name for Her

Aga was no discovery. She was second at the 2026 Berlin Marathon in roughly 2:18:34 and won the 2026 Tokyo Marathon in roughly 2:20:40 — both figures from external records, not from the source report, so I am treating them as pending verification. She has three second-place finishes at World Marathon Majors.

A six-year ban and the end of a career are different things. On the day the ban arrived, Tokyo 2026 was still in her file. The report does not state the scope of disqualification. Unless the panel found an earlier violation, the 2026 title does not fall automatically. That distinction is small on paper and load-bearing in a career.

My 2026 notebook has that Tokyo day in it — a rain-soaked course, and a runner who moved clear in the closing ten kilometres without any visible attack, just sustained pressure. That win was hers. A forged prescription does not erase it. I write this because sanctions reporting tends to separate athletes from their entire past, and that is wrong.

The Ethiopian Conveyor, Where One Individual Has No Value

Ethiopian women's marathon depth is the context without which this case makes no sense. A 2:18 does not guarantee national selection here. The current cohort contains sub-2:16 performers, and the pool refills annually — altitude clubs, agent-run camps, a system that produces runners in volume from junior level.

That system has a characteristic nobody discusses: extraordinary depth, minimal individual support. Put thirty runners in one camp and the fastest three get full attention. The remaining twenty-seven handle their own injuries, medication and paperwork. Aga was not in that twenty-seven — she had won Majors — but the medical structure around her is visibly far below professional standards anywhere else.

This is not a flaw in the system. It is the system's architecture. And the hole opens precisely where money meets injury.

The Arithmetic: Two Plus Four

I read sanctions by their sum, because sums do not lie. Two years for presence, four for tampering. Four years is the Code's standard tampering sanction. Two years for presence indicates a Specified Substance finding without proven intent.

There is a paradox I will not skip. A forged document is itself circumstantial evidence of concealment intent. Yet it did not aggravate the presence sanction. The panel kept the two in separate boxes — substance in the body, then a lie told afterwards — and added them without threading one through the other. Technically correct. Morally strange, because the real question is which came first, the lie or the medicine.

The Pharmacology Error Running Through Every Headline

Methylprednisolone is not an anabolic steroid. It is a glucocorticoid, WADA Prohibited List class S9, not S1. Under the current List, S9 glucocorticoids are prohibited in-competition only, by injection, oral or rectal routes.

The consequence: this is not a steroid case. It is a case about route, timing, and whether residue remained on race day. A therapeutic injection given out-of-competition is entirely lawful. It becomes a violation only if residue is present in-competition.

That distinction is the whole case. A genuinely documented treatment would have been defended with real records. Instead a prescription was manufactured, and the only defence that could have worked was destroyed.

The Road-Race Testing Window and Its Merciless Arithmetic

In road racing the in-competition window opens at 23:59 the day before the race. A marathoner who takes a knee injection on Friday and races on Sunday is in arithmetic trouble even when the treatment is fully justified. Precise washout figures depend on route, dose and individual; I will not print a number I cannot source, because the page with the number is the page I need to see.

The principle is clear. A managed athlete either holds a Therapeutic Use Exemption or times the treatment so no residue survives to race day. No indication exists that Aga did either. What happened instead was a document.

The Knee: The Real Root Cause

Peri-articular or intra-articular methylprednisolone for knee synovitis is standard sports-medicine practice in distance runners. The excuse is not invented. The forgery is decisive precisely because the excuse is plausible: real treatments are defended with real records.

Chronic knee pathology is a known failure mode in high-volume marathoners. At 32 this is not sudden. It accumulates. And when a runner has managed a chronic joint for years, the management is usually informal — which is exactly where governance fails.

Three Checks, Three Failures

The clinic from which the prescription was said to have been issued did not exist. The "doctor" was a family member with no medical registration. That person claimed an old prescription pad from a former workplace, which the clinic in question explicitly disowned.

Three independent verification failures at three independent points. That is not a mistake; a mistake happens in one place. That is a structure with no verification step built into it at all.

And here a name is missing. AIU's statement names only the family member. Whether an agent, manager or training partner was investigated is unrecorded. Every elite runner has four or five people who handle paperwork. None appear to have asked where the slip came from. I will not fill the gap. I will record it.

What a Competent Defence Looks Like

A TUE for chronic knee inflammation, or correct timing, or transparency — real records, real clinic, real doctor — could have produced a no-significant-fault finding and a heavily reduced period. And if nothing had been fabricated, there would be no four-year tampering charge at all. That is the largest cost here: the cover-up outweighed the offence.

Thirty-Two to Thirty-Eight

Peak women's marathon performance clusters between 28 and 32, then declines slowly. Returning at 38 is theoretically possible and practically closed, because Ethiopian selection at 2:18 is already a bottleneck. Add a doping record and an appearance-fee market that treats it as a commercial embargo in a sport with thin distance-running sponsorship. The sanction is functionally career-terminal.

China's Label Circuit: Where Prize Money and Testing Collide

The March race was almost certainly a World Athletics Label road race with an elite women's field, or there would be no AIU sample. This circuit is a dependable income tier for East African marathoners between Majors: good appearance fees, manageable fields, limited risk. It is now the AIU's highest-yield testing ground.

The economy of appearance fees and the economy of testing are colliding in the same races, and that collision will shape road running's next decade.

The Pattern That Is Not Singular

Across recent East African road-running cases, the pattern repeats: small first violation, larger second one. A technical cause sits underneath. Athletes who believe a glucocorticoid injection is banned outright hide it; it is legal out-of-competition. Information failure converts a legal treatment into a tampering charge. Sixty calls went out into an empty year in 2026 and this is what came back most often: we did not know that was the rule.

The Contrarian Angle: Six Years for a Substance With No Proven Endurance Benefit

Methylprednisolone reduces inflammation. It has no proven endurance benefit — it does not raise speed, lactate threshold or oxygen utilisation. It is a medical substance, not a performance drug. When an EPO case and a knee-injection case draw near-comparable bans, the credibility of the system is the thing on trial.

And note where the bulk of this ban came from. Not the medicine. The lie. A system that gives six years for a knee injection while giving four for systematic blood doping cannot tell us what it fears most. Questioning proportionality is not excusing forgery. In this case, nobody asked.

The Accountability Vacuum

When a family member forges a prescription, two things are true at once: the athlete's responsibility does not shrink, and her dependency becomes visible. The Ethiopian federation is not quoted anywhere in this report. Only AIU. That silence is itself information, and a missing page in my file. The CAS appeal window, typically around 21 days, is probably open; a document-based tampering finding is very hard to overturn.

What Survives

The Tokyo 2026 title survives, absent a finding of earlier violation. Three Major second places survive. A file that was opened before the world had a name for her survives. That is a strange kind of relief. A career has two parts — what the legs did and what the decisions did — and they must be kept apart or the history will be written out of spite. The second part tends to eat the first. Tokyo 2026 will now always be read with a parenthesis attached, not because anyone proved something was wrong that day, but because that is how we read.

What Comes Next

Three things matter. Get the substance name right, because misinformation drives the very fear that produced this forged slip — the cheapest prevention available and the least used. Build digital medical ledgers for every athlete in the East African training clusters, because what is written down does not get forged. And test proportionality, honestly, because a career should not fall on a substance with no proven benefit — and if it must, someone has to prove the ratio holds. It does not.

Next time a headline says a runner got six years for "steroids", ask for the date. The date first. Then the argument.